Cadila Healthcare extends tenure of JV agreement with Bayer (South East Asia)

Cadila Healthcare as a joint venture partner, has signed an agreement to extend the tenure of the joint venture agreement (JVA) with Bayer (South East Asia), one of the companies of the Bayer Group, for a further period of two months to explore the possibilities of further collaboration.

Powered by Capital Market - Live News